UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
December 31, 2014
MAGELLAN HEALTH, INC.
(Exact Name of Registrant as Specified in Charter)
|
DELAWARE |
|
1-6639 |
|
58-1076937 |
|
(State or Other Jurisdiction |
|
(Commission File |
|
(IRS Employer |
|
of Incorporation) |
|
Number) |
|
Identification No.) |
|
4800 SCOTTSDALE RD, SUITE 4400 |
|
|
|
SCOTTSDALE, ARIZONA |
|
85251 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (602) 572-6050
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Matters
As disclosed in the Magellan Health, Inc. (the “Company”) Form 10-Q, filed on October 24, 2014, the Company has a contract with one of the significant customers in its Specialty Solutions segment with a term ending July 31, 2015 that generated revenue of $55.8 million for the nine months ended September 30, 2014. On December 31, 2014, the Company and this customer agreed to extend this contract through at least June 30, 2017.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MAGELLAN HEALTH, INC.
|
Date: January 5, 2015 |
By: |
/s/ Jonathan N. Rubin |
|
|
|
Name: Jonathan N. Rubin |
|
|
|
Title: Executive Vice President and Chief Financial Officer |